Avadel pharmaceuticals to present at the h.c. wainwright 3rd annual bioconnect investor conference

Dublin, may 13, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the h.c. wainwright 3rd annual bioconnect investor conference on tuesday, may 20 at 12:00 p.m.
AVDL Ratings Summary
AVDL Quant Ranking